Rep. Lisa C. McClain Buys Zoetis Inc. (NYSE:ZTS) Shares

Key Points

• Representative Lisa C. McClain purchased shares of Zoetis Inc. (NYSE:ZTS) for an amount between $1,001 and $15,000, with the transaction taking place on July 22nd.
• Zoetis recently reported a quarterly earnings per share of $1.76, which exceeded analysts' expectations of $1.62, along with a net margin of 27.83% and an annual revenue increase of 4.2% year-over-year.
• The company declared a quarterly dividend of $0.50 per share, with an annualized basis of $2.00 and a yield of 1.3%, set to be paid on September 3rd.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Zoetis Inc. NYSE: ZTS. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Zoetis stock on July 22nd. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Zoetis Price Performance

Zoetis stock traded down $1.83 during mid-day trading on Monday, reaching $152.28. The company had a trading volume of 2,158,515 shares, compared to its average volume of 3,678,922. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock's 50-day simple moving average is $154.69 and its 200-day simple moving average is $158.90. Zoetis Inc. has a 1 year low of $139.70 and a 1 year high of $200.33. The company has a market capitalization of $67.49 billion, a P/E ratio of 26.21, a P/E/G ratio of 2.47 and a beta of 0.88.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The business had revenue of $2.46 billion during the quarter, compared to analysts' expectations of $2.41 billion. During the same period last year, the company posted $1.56 EPS. The company's revenue was up 4.2% on a year-over-year basis. On average, equities analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.3%. Zoetis's dividend payout ratio (DPR) is 34.42%.

Insider Buying and Selling at Zoetis

In related news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total transaction of $110,840.00. Following the transaction, the executive vice president owned 15,129 shares in the company, valued at approximately $2,571,930. The trade was a 4.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.16% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have commented on ZTS shares. Leerink Partners cut shares of Zoetis from an "outperform" rating to a "market perform" rating and lowered their target price for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Stifel Nicolaus cut shares of Zoetis from a "buy" rating to a "hold" rating and lowered their target price for the stock from $165.00 to $160.00 in a research note on Wednesday, June 18th. Leerink Partnrs cut shares of Zoetis from a "strong-buy" rating to a "hold" rating in a research note on Thursday, July 17th. UBS Group lowered their target price on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research note on Wednesday, May 7th. Finally, Piper Sandler lifted their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $202.43.

Hedge Funds Weigh In On Zoetis

A number of hedge funds have recently made changes to their positions in the stock. Old North State Trust LLC boosted its holdings in shares of Zoetis by 46.5% in the 2nd quarter. Old North State Trust LLC now owns 2,112 shares of the company's stock valued at $329,000 after purchasing an additional 670 shares during the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of Zoetis by 14.6% in the 2nd quarter. Geneos Wealth Management Inc. now owns 24,960 shares of the company's stock valued at $3,893,000 after purchasing an additional 3,171 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Zoetis in the 2nd quarter valued at $187,000. Rexford Capital Inc. acquired a new position in shares of Zoetis in the 2nd quarter valued at $165,000. Finally, Parr Mcknight Wealth Management Group LLC lifted its holdings in shares of Zoetis by 12.0% during the 2nd quarter. Parr Mcknight Wealth Management Group LLC now owns 18,622 shares of the company's stock valued at $2,904,000 after acquiring an additional 1,995 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.